Budget Amount *help |
¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000)
Fiscal Year 2014: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2012: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
|
Outline of Final Research Achievements |
We analyzed the serum microRNA in patients with pancreatic cancer by microarray. The results showed that hsa-miR-188-5p, hsa-miR-1275 and hsa-miR-3648 were significantly higher in pancreatic cancer patients than those in healthy volunteer or patients with benign pancreatic disorders. Especially, miR-1275 increased 3.6 times in average. In future, we have a plan to analyze the role and function of these microRNA in pancreatic cancer.
|